Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Phase II anetumab ravtansine as 2nd line treatment for malignant pleural mesothelioma
Clinical Trial Grant
Duke Scholars
Principal Investigator
Jeffrey Crawford
Medicine, Medical Oncology
Awarded By
Bayer HealthCare AG
Start Date
July 1, 2016
End Date
July 31, 2018
Awarded By
Bayer HealthCare AG
Start Date
July 1, 2016
End Date
July 31, 2018
